Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Acquires Crop Biotech Firm Grassroots Biotechnology

NEW YORK (GenomeWeb News) – Monsanto has acquired agricultural biotechnology firm GrassRoots Biotechnology for an undisclosed amount.

The acquisition was made earlier this month, and in an e-mail to GenomeWeb Daily News, a Monsanto spokesperson said, "GrassRoots focuses on gene expression and other agricultural technologies that will complement Monsanto's biotechnology research and development work."

All research employees will be offered positions at Monsanto. The spokesperson declined to disclose further terms of the deal.

GrassRoots was spun out of Duke University in 2007 to commercialize technologies developed by Philip Benfey, who, with Doug Eisner, co-founded the firm. Among the products and services it offers are gene regulation, root trait optimization, trait gene discovery, and agricultural chemical analysis, according to its website.

The Durham, NC-based firm first entered into a technology alliance and licensing deal with Monsanto in early 2009 focused on discovering gene promoters and trait genes for agricultural crops, and in 2011, the two companies extended their agreement two years through January 2014.

At the time, Monsanto planned to use expression elements sourced from GrassRoots "to optimize an array of biotechnology traits in a broad range of crops, including corn, soy, cotton, and canola," the companies said.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.